Literature DB >> 1951309

Sickle cell disease and hemochromatosis.

M E Conrad1.   

Abstract

A 50 year-old patient with sickle cell anemia was seen who had received only two units of blood during his lifetime. He had marked iron overloading, cirrhosis of the liver, arthralgia, and mild glucose intolerance. We believe the iron overloading was associated with hereditary hemochromatosis rather than sickle cell anemia because he had HLA-A3 and B7 antigens, and hepatic iron deposits were primarily in parenchymal cells rather than Kupfer cells. The coexistence of either homozygous or heterozygous hemochromatosis should be suspected in sickle cell patients with organ damage from iron overloading.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951309     DOI: 10.1002/ajh.2830380217

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

1.  Hemosiderosis causing liver cirrhosis in a patient with Hb S/beta thalassemia and no other known causes of hepatic disease.

Authors:  C Demosthenous; G Rizos; E Vlachaki; G Tzatzagou; M Gavra
Journal:  Hippokratia       Date:  2017 Jan-Mar       Impact factor: 0.471

Review 2.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

3.  Stainable hepatic iron in 341 African American adults at coroner/medical examiner autopsy.

Authors:  James C Barton; Ronald T Acton; Asia K Richardson; Robert M Brissie
Journal:  BMC Clin Pathol       Date:  2005-01-10

4.  Hepatic iron in African Americans who underwent liver biopsy.

Authors:  James C Barton; Luigi F Bertoli; Thomas J Alford; J Clayborn Barton; Corwin Q Edwards
Journal:  Am J Med Sci       Date:  2015-01       Impact factor: 2.378

5.  Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis.

Authors:  A Höblinger; C Erdmann; C P Strassburg; T Sauerbruch; F Lammert
Journal:  Eur J Med Res       Date:  2009-04-16       Impact factor: 2.175

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.